Medication — compliance or alliance? A client-centred approach to increasing adherence

Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder

“…It had a prospective design, although the sample was small and the follow-up period relatively short. In planning the study, we tried to take into account at least some of the critics on former studies on compliance [20] like the retrospective design, heterogeneity of samples and the use of univariate statistical analyses. Our sample was unified, consisting of young male patients suffering from first-episode psychosis and living mostly with the primary family.…”

“…There is a wide range of definitions and measures used in the studies on compliance, so the results are hard to compare. According to Piatkowska [20] the samples are often too small, heterogeneous, and diagnostically ill-defined. Most studies were retrospective, not well controlled, and the results, although statistically significant, show dubious clinical value.…”

From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication

“…Other factors that are suggested within the literature as affecting compliance, but lacking any empirical evidence, include the complexity of treatment regimens (Parkin et al . 1976) and the patient’s sociocultural background (Piatkowska & Farnill 1992).…”

An Intervention for Substance Abuse in Schizophrenia

“…Since substance use is sometimes an alternative to antipsychotic medication, or a way to control side effects, maximising adherence to effective medication is a key objective of the intervention. Procedures to maximise adherence are described in Piatkowska and Farnill (1992). Level of adherence is assessed, and reasons for nonadherence are examined.…”